Global CRISPR-Based Therapeutics Market Growth (Status and Outlook) 2025-2031

September 2025 | 101 pages | ID: GB8002AA22B7EN
LP Information

Abstracts

According to this study, the global CRISPR-Based Therapeutics market size will reach US$ million by 2031.

CRISPR?based genome editing technology has become an important potential therapeutic tool for various diseases.

United States market for CRISPR-Based Therapeutics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for CRISPR-Based Therapeutics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for CRISPR-Based Therapeutics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key CRISPR-Based Therapeutics players cover Caribou Biosciences, Addgene, CRISPR THERAPEUTICS, Merck KGaA, Mirus Bio LLC, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “CRISPR-Based Therapeutics Industry Forecast” looks at past sales and reviews total world CRISPR-Based Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected CRISPR-Based Therapeutics sales for 2025 through 2031. With CRISPR-Based Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CRISPR-Based Therapeutics industry.

This Insight Report provides a comprehensive analysis of the global CRISPR-Based Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on CRISPR-Based Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global CRISPR-Based Therapeutics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CRISPR-Based Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CRISPR-Based Therapeutics.

This report presents a comprehensive overview, market shares, and growth opportunities of CRISPR-Based Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Genome Editing
• Genetic Engineering
• gRNA Database/Gene Librar
• CRISPR Plasmid
• Human Stem Cells
• Genetically Modified Organisms/Crops
• Cell Line Engineering

Segmentation by Application:

• Biotechnology Companies
• Pharmaceutical Companies
• Academic Institutes
• Research and Development Institutes

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Caribou Biosciences
• Addgene
• CRISPR THERAPEUTICS
• Merck KGaA
• Mirus Bio LLC
• Editas Medicine
• Takara Bio USA
• Thermo Fisher Scientific
• Horizon Discovery Group
• Intellia Therapeutics
• GE Healthcare Dharmacon

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global CRISPR-Based Therapeutics Market Size (2020-2031)
  2.1.2 CRISPR-Based Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for CRISPR-Based Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 CRISPR-Based Therapeutics Segment by Type
  2.2.1 Genome Editing
  2.2.2 Genetic Engineering
  2.2.3 gRNA Database/Gene Librar
  2.2.4 CRISPR Plasmid
  2.2.5 Human Stem Cells
  2.2.6 Genetically Modified Organisms/Crops
  2.2.7 Cell Line Engineering
2.3 CRISPR-Based Therapeutics Market Size by Type
  2.3.1 CRISPR-Based Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global CRISPR-Based Therapeutics Market Size Market Share by Type (2020-2025)
2.4 CRISPR-Based Therapeutics Segment by Application
  2.4.1 Biotechnology Companies
  2.4.2 Pharmaceutical Companies
  2.4.3 Academic Institutes
  2.4.4 Research and Development Institutes
2.5 CRISPR-Based Therapeutics Market Size by Application
  2.5.1 CRISPR-Based Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global CRISPR-Based Therapeutics Market Size Market Share by Application (2020-2025)

3 CRISPR-BASED THERAPEUTICS MARKET SIZE BY PLAYER

3.1 CRISPR-Based Therapeutics Market Size Market Share by Player
  3.1.1 Global CRISPR-Based Therapeutics Revenue by Player (2020-2025)
  3.1.2 Global CRISPR-Based Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global CRISPR-Based Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CRISPR-BASED THERAPEUTICS BY REGION

4.1 CRISPR-Based Therapeutics Market Size by Region (2020-2025)
4.2 Global CRISPR-Based Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas CRISPR-Based Therapeutics Market Size Growth (2020-2025)
4.4 APAC CRISPR-Based Therapeutics Market Size Growth (2020-2025)
4.5 Europe CRISPR-Based Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa CRISPR-Based Therapeutics Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas CRISPR-Based Therapeutics Market Size by Country (2020-2025)
5.2 Americas CRISPR-Based Therapeutics Market Size by Type (2020-2025)
5.3 Americas CRISPR-Based Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC CRISPR-Based Therapeutics Market Size by Region (2020-2025)
6.2 APAC CRISPR-Based Therapeutics Market Size by Type (2020-2025)
6.3 APAC CRISPR-Based Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe CRISPR-Based Therapeutics Market Size by Country (2020-2025)
7.2 Europe CRISPR-Based Therapeutics Market Size by Type (2020-2025)
7.3 Europe CRISPR-Based Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa CRISPR-Based Therapeutics by Region (2020-2025)
8.2 Middle East & Africa CRISPR-Based Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa CRISPR-Based Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL CRISPR-BASED THERAPEUTICS MARKET FORECAST

10.1 Global CRISPR-Based Therapeutics Forecast by Region (2026-2031)
  10.1.1 Global CRISPR-Based Therapeutics Forecast by Region (2026-2031)
  10.1.2 Americas CRISPR-Based Therapeutics Forecast
  10.1.3 APAC CRISPR-Based Therapeutics Forecast
  10.1.4 Europe CRISPR-Based Therapeutics Forecast
  10.1.5 Middle East & Africa CRISPR-Based Therapeutics Forecast
10.2 Americas CRISPR-Based Therapeutics Forecast by Country (2026-2031)
  10.2.1 United States Market CRISPR-Based Therapeutics Forecast
  10.2.2 Canada Market CRISPR-Based Therapeutics Forecast
  10.2.3 Mexico Market CRISPR-Based Therapeutics Forecast
  10.2.4 Brazil Market CRISPR-Based Therapeutics Forecast
10.3 APAC CRISPR-Based Therapeutics Forecast by Region (2026-2031)
  10.3.1 China CRISPR-Based Therapeutics Market Forecast
  10.3.2 Japan Market CRISPR-Based Therapeutics Forecast
  10.3.3 Korea Market CRISPR-Based Therapeutics Forecast
  10.3.4 Southeast Asia Market CRISPR-Based Therapeutics Forecast
  10.3.5 India Market CRISPR-Based Therapeutics Forecast
  10.3.6 Australia Market CRISPR-Based Therapeutics Forecast
10.4 Europe CRISPR-Based Therapeutics Forecast by Country (2026-2031)
  10.4.1 Germany Market CRISPR-Based Therapeutics Forecast
  10.4.2 France Market CRISPR-Based Therapeutics Forecast
  10.4.3 UK Market CRISPR-Based Therapeutics Forecast
  10.4.4 Italy Market CRISPR-Based Therapeutics Forecast
  10.4.5 Russia Market CRISPR-Based Therapeutics Forecast
10.5 Middle East & Africa CRISPR-Based Therapeutics Forecast by Region (2026-2031)
  10.5.1 Egypt Market CRISPR-Based Therapeutics Forecast
  10.5.2 South Africa Market CRISPR-Based Therapeutics Forecast
  10.5.3 Israel Market CRISPR-Based Therapeutics Forecast
  10.5.4 Turkey Market CRISPR-Based Therapeutics Forecast
10.6 Global CRISPR-Based Therapeutics Forecast by Type (2026-2031)
10.7 Global CRISPR-Based Therapeutics Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market CRISPR-Based Therapeutics Forecast

11 KEY PLAYERS ANALYSIS

11.1 Caribou Biosciences
  11.1.1 Caribou Biosciences Company Information
  11.1.2 Caribou Biosciences CRISPR-Based Therapeutics Product Offered
  11.1.3 Caribou Biosciences CRISPR-Based Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Caribou Biosciences Main Business Overview
  11.1.5 Caribou Biosciences Latest Developments
11.2 Addgene
  11.2.1 Addgene Company Information
  11.2.2 Addgene CRISPR-Based Therapeutics Product Offered
  11.2.3 Addgene CRISPR-Based Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Addgene Main Business Overview
  11.2.5 Addgene Latest Developments
11.3 CRISPR THERAPEUTICS
  11.3.1 CRISPR THERAPEUTICS Company Information
  11.3.2 CRISPR THERAPEUTICS CRISPR-Based Therapeutics Product Offered
  11.3.3 CRISPR THERAPEUTICS CRISPR-Based Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 CRISPR THERAPEUTICS Main Business Overview
  11.3.5 CRISPR THERAPEUTICS Latest Developments
11.4 Merck KGaA
  11.4.1 Merck KGaA Company Information
  11.4.2 Merck KGaA CRISPR-Based Therapeutics Product Offered
  11.4.3 Merck KGaA CRISPR-Based Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Merck KGaA Main Business Overview
  11.4.5 Merck KGaA Latest Developments
11.5 Mirus Bio LLC
  11.5.1 Mirus Bio LLC Company Information
  11.5.2 Mirus Bio LLC CRISPR-Based Therapeutics Product Offered
  11.5.3 Mirus Bio LLC CRISPR-Based Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Mirus Bio LLC Main Business Overview
  11.5.5 Mirus Bio LLC Latest Developments
11.6 Editas Medicine
  11.6.1 Editas Medicine Company Information
  11.6.2 Editas Medicine CRISPR-Based Therapeutics Product Offered
  11.6.3 Editas Medicine CRISPR-Based Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Editas Medicine Main Business Overview
  11.6.5 Editas Medicine Latest Developments
11.7 Takara Bio USA
  11.7.1 Takara Bio USA Company Information
  11.7.2 Takara Bio USA CRISPR-Based Therapeutics Product Offered
  11.7.3 Takara Bio USA CRISPR-Based Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Takara Bio USA Main Business Overview
  11.7.5 Takara Bio USA Latest Developments
11.8 Thermo Fisher Scientific
  11.8.1 Thermo Fisher Scientific Company Information
  11.8.2 Thermo Fisher Scientific CRISPR-Based Therapeutics Product Offered
  11.8.3 Thermo Fisher Scientific CRISPR-Based Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Thermo Fisher Scientific Main Business Overview
  11.8.5 Thermo Fisher Scientific Latest Developments
11.9 Horizon Discovery Group
  11.9.1 Horizon Discovery Group Company Information
  11.9.2 Horizon Discovery Group CRISPR-Based Therapeutics Product Offered
  11.9.3 Horizon Discovery Group CRISPR-Based Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Horizon Discovery Group Main Business Overview
  11.9.5 Horizon Discovery Group Latest Developments
11.10 Intellia Therapeutics
  11.10.1 Intellia Therapeutics Company Information
  11.10.2 Intellia Therapeutics CRISPR-Based Therapeutics Product Offered
  11.10.3 Intellia Therapeutics CRISPR-Based Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Intellia Therapeutics Main Business Overview
  11.10.5 Intellia Therapeutics Latest Developments
11.11 GE Healthcare Dharmacon
  11.11.1 GE Healthcare Dharmacon Company Information
  11.11.2 GE Healthcare Dharmacon CRISPR-Based Therapeutics Product Offered
  11.11.3 GE Healthcare Dharmacon CRISPR-Based Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 GE Healthcare Dharmacon Main Business Overview
  11.11.5 GE Healthcare Dharmacon Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. CRISPR-Based Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. CRISPR-Based Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Genome Editing
Table 4. Major Players of Genetic Engineering
Table 5. Major Players of gRNA Database/Gene Librar
Table 6. Major Players of CRISPR Plasmid
Table 7. Major Players of Human Stem Cells
Table 8. Major Players of Genetically Modified Organisms/Crops
Table 9. Major Players of Cell Line Engineering
Table 10. CRISPR-Based Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global CRISPR-Based Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 12. Global CRISPR-Based Therapeutics Market Size Market Share by Type (2020-2025)
Table 13. CRISPR-Based Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 14. Global CRISPR-Based Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 15. Global CRISPR-Based Therapeutics Market Size Market Share by Application (2020-2025)
Table 16. Global CRISPR-Based Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 17. Global CRISPR-Based Therapeutics Revenue Market Share by Player (2020-2025)
Table 18. CRISPR-Based Therapeutics Key Players Head office and Products Offered
Table 19. CRISPR-Based Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global CRISPR-Based Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 23. Global CRISPR-Based Therapeutics Market Size Market Share by Region (2020-2025)
Table 24. Global CRISPR-Based Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 25. Global CRISPR-Based Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 26. Americas CRISPR-Based Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 27. Americas CRISPR-Based Therapeutics Market Size Market Share by Country (2020-2025)
Table 28. Americas CRISPR-Based Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 29. Americas CRISPR-Based Therapeutics Market Size Market Share by Type (2020-2025)
Table 30. Americas CRISPR-Based Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 31. Americas CRISPR-Based Therapeutics Market Size Market Share by Application (2020-2025)
Table 32. APAC CRISPR-Based Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 33. APAC CRISPR-Based Therapeutics Market Size Market Share by Region (2020-2025)
Table 34. APAC CRISPR-Based Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 35. APAC CRISPR-Based Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 36. Europe CRISPR-Based Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 37. Europe CRISPR-Based Therapeutics Market Size Market Share by Country (2020-2025)
Table 38. Europe CRISPR-Based Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 39. Europe CRISPR-Based Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 40. Middle East & Africa CRISPR-Based Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 41. Middle East & Africa CRISPR-Based Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 42. Middle East & Africa CRISPR-Based Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 43. Key Market Drivers & Growth Opportunities of CRISPR-Based Therapeutics
Table 44. Key Market Challenges & Risks of CRISPR-Based Therapeutics
Table 45. Key Industry Trends of CRISPR-Based Therapeutics
Table 46. Global CRISPR-Based Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 47. Global CRISPR-Based Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 48. Global CRISPR-Based Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 49. Global CRISPR-Based Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 50. Caribou Biosciences Details, Company Type, CRISPR-Based Therapeutics Area Served and Its Competitors
Table 51. Caribou Biosciences CRISPR-Based Therapeutics Product Offered
Table 52. Caribou Biosciences CRISPR-Based Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Caribou Biosciences Main Business
Table 54. Caribou Biosciences Latest Developments
Table 55. Addgene Details, Company Type, CRISPR-Based Therapeutics Area Served and Its Competitors
Table 56. Addgene CRISPR-Based Therapeutics Product Offered
Table 57. Addgene CRISPR-Based Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Addgene Main Business
Table 59. Addgene Latest Developments
Table 60. CRISPR THERAPEUTICS Details, Company Type, CRISPR-Based Therapeutics Area Served and Its Competitors
Table 61. CRISPR THERAPEUTICS CRISPR-Based Therapeutics Product Offered
Table 62. CRISPR THERAPEUTICS CRISPR-Based Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. CRISPR THERAPEUTICS Main Business
Table 64. CRISPR THERAPEUTICS Latest Developments
Table 65. Merck KGaA Details, Company Type, CRISPR-Based Therapeutics Area Served and Its Competitors
Table 66. Merck KGaA CRISPR-Based Therapeutics Product Offered
Table 67. Merck KGaA CRISPR-Based Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Merck KGaA Main Business
Table 69. Merck KGaA Latest Developments
Table 70. Mirus Bio LLC Details, Company Type, CRISPR-Based Therapeutics Area Served and Its Competitors
Table 71. Mirus Bio LLC CRISPR-Based Therapeutics Product Offered
Table 72. Mirus Bio LLC CRISPR-Based Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Mirus Bio LLC Main Business
Table 74. Mirus Bio LLC Latest Developments
Table 75. Editas Medicine Details, Company Type, CRISPR-Based Therapeutics Area Served and Its Competitors
Table 76. Editas Medicine CRISPR-Based Therapeutics Product Offered
Table 77. Editas Medicine CRISPR-Based Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Editas Medicine Main Business
Table 79. Editas Medicine Latest Developments
Table 80. Takara Bio USA Details, Company Type, CRISPR-Based Therapeutics Area Served and Its Competitors
Table 81. Takara Bio USA CRISPR-Based Therapeutics Product Offered
Table 82. Takara Bio USA CRISPR-Based Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Takara Bio USA Main Business
Table 84. Takara Bio USA Latest Developments
Table 85. Thermo Fisher Scientific Details, Company Type, CRISPR-Based Therapeutics Area Served and Its Competitors
Table 86. Thermo Fisher Scientific CRISPR-Based Therapeutics Product Offered
Table 87. Thermo Fisher Scientific CRISPR-Based Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Thermo Fisher Scientific Main Business
Table 89. Thermo Fisher Scientific Latest Developments
Table 90. Horizon Discovery Group Details, Company Type, CRISPR-Based Therapeutics Area Served and Its Competitors
Table 91. Horizon Discovery Group CRISPR-Based Therapeutics Product Offered
Table 92. Horizon Discovery Group CRISPR-Based Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Horizon Discovery Group Main Business
Table 94. Horizon Discovery Group Latest Developments
Table 95. Intellia Therapeutics Details, Company Type, CRISPR-Based Therapeutics Area Served and Its Competitors
Table 96. Intellia Therapeutics CRISPR-Based Therapeutics Product Offered
Table 97. Intellia Therapeutics CRISPR-Based Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Intellia Therapeutics Main Business
Table 99. Intellia Therapeutics Latest Developments
Table 100. GE Healthcare Dharmacon Details, Company Type, CRISPR-Based Therapeutics Area Served and Its Competitors
Table 101. GE Healthcare Dharmacon CRISPR-Based Therapeutics Product Offered
Table 102. GE Healthcare Dharmacon CRISPR-Based Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. GE Healthcare Dharmacon Main Business
Table 104. GE Healthcare Dharmacon Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. CRISPR-Based Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CRISPR-Based Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. CRISPR-Based Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. CRISPR-Based Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. CRISPR-Based Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global CRISPR-Based Therapeutics Market Size Market Share by Type in 2024
Figure 10. CRISPR-Based Therapeutics in Biotechnology Companies
Figure 11. Global CRISPR-Based Therapeutics Market: Biotechnology Companies (2020-2025) & ($ millions)
Figure 12. CRISPR-Based Therapeutics in Pharmaceutical Companies
Figure 13. Global CRISPR-Based Therapeutics Market: Pharmaceutical Companies (2020-2025) & ($ millions)
Figure 14. CRISPR-Based Therapeutics in Academic Institutes
Figure 15. Global CRISPR-Based Therapeutics Market: Academic Institutes (2020-2025) & ($ millions)
Figure 16. CRISPR-Based Therapeutics in Research and Development Institutes
Figure 17. Global CRISPR-Based Therapeutics Market: Research and Development Institutes (2020-2025) & ($ millions)
Figure 18. Global CRISPR-Based Therapeutics Market Size Market Share by Application in 2024
Figure 19. Global CRISPR-Based Therapeutics Revenue Market Share by Player in 2024
Figure 20. Global CRISPR-Based Therapeutics Market Size Market Share by Region (2020-2025)
Figure 21. Americas CRISPR-Based Therapeutics Market Size 2020-2025 ($ millions)
Figure 22. APAC CRISPR-Based Therapeutics Market Size 2020-2025 ($ millions)
Figure 23. Europe CRISPR-Based Therapeutics Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa CRISPR-Based Therapeutics Market Size 2020-2025 ($ millions)
Figure 25. Americas CRISPR-Based Therapeutics Value Market Share by Country in 2024
Figure 26. United States CRISPR-Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada CRISPR-Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico CRISPR-Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil CRISPR-Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC CRISPR-Based Therapeutics Market Size Market Share by Region in 2024
Figure 31. APAC CRISPR-Based Therapeutics Market Size Market Share by Type (2020-2025)
Figure 32. APAC CRISPR-Based Therapeutics Market Size Market Share by Application (2020-2025)
Figure 33. China CRISPR-Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan CRISPR-Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea CRISPR-Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia CRISPR-Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. India CRISPR-Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia CRISPR-Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe CRISPR-Based Therapeutics Market Size Market Share by Country in 2024
Figure 40. Europe CRISPR-Based Therapeutics Market Size Market Share by Type (2020-2025)
Figure 41. Europe CRISPR-Based Therapeutics Market Size Market Share by Application (2020-2025)
Figure 42. Germany CRISPR-Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. France CRISPR-Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 44. UK CRISPR-Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy CRISPR-Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia CRISPR-Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa CRISPR-Based Therapeutics Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa CRISPR-Based Therapeutics Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa CRISPR-Based Therapeutics Market Size Market Share by Application (2020-2025)
Figure 50. Egypt CRISPR-Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa CRISPR-Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel CRISPR-Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey CRISPR-Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries CRISPR-Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas CRISPR-Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 56. APAC CRISPR-Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 57. Europe CRISPR-Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa CRISPR-Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. United States CRISPR-Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Canada CRISPR-Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. Mexico CRISPR-Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Brazil CRISPR-Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. China CRISPR-Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Japan CRISPR-Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. Korea CRISPR-Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia CRISPR-Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. India CRISPR-Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. Australia CRISPR-Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. Germany CRISPR-Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. France CRISPR-Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. UK CRISPR-Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. Italy CRISPR-Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. Russia CRISPR-Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Egypt CRISPR-Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. South Africa CRISPR-Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Israel CRISPR-Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 77. Turkey CRISPR-Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 78. Global CRISPR-Based Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global CRISPR-Based Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries CRISPR-Based Therapeutics Market Size 2026-2031 ($ millions)